Resection of Intrathoracic Paraganglioma With and Without Cardiopulmonary Bypass.

[1]  W. Young,et al.  Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years , 2017, The Journal of clinical endocrinology and metabolism.

[2]  D. Schroeder,et al.  Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection. , 2017, Urology.

[3]  R. Cerfolio,et al.  Cardiac Paraganglioma , 2015, Journal of cardiac surgery.

[4]  Jigang Wang,et al.  Cardiac Paragangliomas , 2015, Journal of cardiac surgery.

[5]  S. G. Romero,et al.  Surgical excision with left atrial reconstruction of a primary functioning retrocardiac paraganglioma , 2013, Journal of Cardiothoracic Surgery.

[6]  I. Al-Githmi Primary Cardiac Pheochromocytoma (Paraganglioma) , 2011 .

[7]  G. Thompson,et al.  Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. , 2010, Urology.

[8]  S. Chan,et al.  Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management. , 2010, Singapore medical journal.

[9]  M. Abel,et al.  Mediastinal paragangliomas: the mayo clinic experience. , 2008, The Annals of thoracic surgery.

[10]  D. Mikhailidis,et al.  Pheochromocytoma: an update on genetics and management. , 2007, Endocrine-related cancer.

[11]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[12]  W. Young,et al.  The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic Experience , 2003 .

[13]  E. Bravo,et al.  Pheochromocytoma: state-of-the-art and future prospects. , 2003, Endocrine reviews.

[14]  J. Yoshikawa,et al.  A dopamine-secreting pheochromocytoma. , 1999, Journal of Cardiovascular Pharmacology.

[15]  A. Novick,et al.  Successful outcomes in pheochromocytoma surgery in the modern era. , 1999, The Journal of urology.

[16]  V. Jeevanandam,et al.  Surgical Management of Cardiac Pheochromocytoma Resection Versus Transplantation , 1995, Annals of surgery.

[17]  A. Boutros,et al.  Perioperative management of 63 patients with pheochromocytoma. , 1990, Cleveland Clinic journal of medicine.

[18]  P. Fossati,et al.  Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. , 1986, Surgery.

[19]  G. Tsujimoto,et al.  Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system , 1985, Heart and Vessels.

[20]  M. Orringer,et al.  Surgical treatment of cardiac pheochromocytomas. , 1985, The Journal of thoracic and cardiovascular surgery.

[21]  G. Tsujimoto,et al.  Desensitization of β-Adrenergic Receptors by Pheochromocytoma , 1984 .

[22]  L. Kurland,et al.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. , 1983, Mayo Clinic proceedings.

[23]  P. Duvaldestin,et al.  Anaesthetic management of patients with phaeochromocytoma. A review of 102 cases. , 1977, British journal of anaesthesia.

[24]  R. Bennett,et al.  An unusual case of intrathoracic phaeochromocytoma. , 1974, The Australian and New Zealand journal of surgery.